Learn about the EA8191/INDICATE study, treating #ProstateCancer that has come back after surgery with apalutamide and targeted radiation based on PET imaging. More information: bit.ly/indicate-trial #pcsm

EA2197 is a randomized phase 2/3 #ClinicalTrial assessing the optimal perioperative approach for patients with incidental #GallbladderCancer. Learn more: bit.ly/EA2197 cc: @skmaithel @WinshipAtEmory

Do you have #HER2positive #BreastCancer? If so, you may be eligible to participate in the phase 2 #ClinicalTrial EA1211/DIRECT, testing if FDG-PET/CT imaging can better predict a patient's response to treatment than the usual approach. Learn more: bit.ly/EA1211

In honor of #BloodCancerAwarenessMonth , learn about #ClinicalTrial EA9171! This trial is studying a potential new treatment for patients with chronic myelogenous #leukemia (#CML). More info: bit.ly/ea9171-study #leusm #BCAM cc: @Dr_AmerZeidan

The EAF223/GABLE clinical study is testing different imaging techniques that could help make better predictions about #BrainCancer progression. Learn more here: bit.ly/gable-trial
cc: @DukeRadiology, @glioblastf, @gbmfoundation

There is one week left to submit an abstract for the 2024 Young Investigator Symposium!

The Symposium is an opportunity for early-career researchers to share their work, connect w/ experienced investigators, & learn about potential research opportunities. ecog-acrin.org/research/mento…

#ClinicalTrial EAQ222CD/CostCOM, led by @GelarehSadigh, is testing the effectiveness of cost communication and financial navigation in patients with #cancer. If you have any newly diagnosed #SolidCancer, you may be able to participate.
bit.ly/EAQ222CD

Have you had surgery for squamous cell carcinoma of the head and neck (#HNSCC) that has come back? If so, you may be able to participate in this study of a potential new treatment. Learn more: bit.ly/ea3191-study #HeadAndNeckCancer #HNCA

ComboMATCH/EAY191-E5 tests how well #sotorasib with or without #panitumumab can treat patients with advanced #SolidTumors. For more information: bit.ly/combomatch-e5 cc: @NCItreatment, @kspencer725, @DocDustyD #PrecisionMedicine

Do you have chronic myelogenous #leukemia (#CML)? If so, you may be able to participate in this study of a potential new treatment. Learn more: bit.ly/ea9171-study #leusm #BloodCancer

Do you have #esophageal or #GastricCancer that has spread to a number of places in your body? If the #cancer has spread to 1–3 places, you may be able to participate in #clinicaltrial EA2183. For more info: bit.ly/ea2183

Do you have #Cancer (any form of #SolidTumor) that has been recently diagnosed, & a new prescription for cancer medication? If so, you may be able to participate in a research study that aims to reduce #FinancialHardship. More info here: bit.ly/EAQ222CD cc: @GelarehSadigh

The #ComboMATCH Study, led by researchers from @StanfordCancer, @MDAndersonNews, @PennCancer, & @NCItreatment, is testing new combinations of anti-#cancer drugs, based on the characteristics of patients’ tumors. Learn more: bit.ly/ComboMATCH #PrecisionMedicine

ComboMATCH/EAY191-E5 tests how well #sotorasib with or without #panitumumab can treat patients with advanced #SolidTumors. For more information: bit.ly/combomatch-e5 cc: @NCItreatment, @kspencer725, @DocDustyD #PrecisionMedicine

.@Dr_AmerZeidan of @SmilowCancer & @YaleCancer is leading clinical study EA9171, testing if adding a new drug to the usual treatment for chronic myelogenous #leukemia could help patients. Learn more: bit.ly/ea9171-study #CML #leusm

In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients with unresectable #ColorectalCancer liver metastases. For more: bit.ly/ea2222-pump cc : @michael_lidsky, @AndreaCercek

ICYMI "E3311 was a multidisciplinary effort by medical oncologists, surgeons, and radiation oncologists, spotlighting the importance of high-level collaboration when treating #headandneckcancer. It was one of the 1st trials to use surgical credentialing."
tinyurl.com/E3311impact

#Clinicaltrial EA8184, led by Dr. Nagi Kumar of @MoffittNews will evaluate if #greentea catechins can help prevent the progression of #prostatecancer in men on active surveillance. Learn more here: bit.ly/ea8184trial #pcsm cc: @jpowsang

#ClinicalTrial EAQ222CD/CostCOM, led by @GelarehSadigh, is testing the effectiveness of cost communication and financial navigation in patients with #cancer. If you have any newly diagnosed #SolidCancer, you may be able to participate. bit.ly/EAQ222CD

Do you have #ProstateCancer that has returned after prostatectomy? If so, you may be able to participate in this study of potential new treatment approaches. Learn more about the EA8191/INDICATE study: bit.ly/ea8191indicate #pcsm #ProstateCancerAware cc: @nehavapiwala

Clinical study EA3191 is testing a new treatment approach for patients with squamous cell carcinoma of the head and neck (#HNSCC) that has come back after initial therapy. Learn more: bit.ly/ea3191-study #HeadAndNeckCancer #HNCA

Do you have advanced non-small cell #LungCancer and are aged 70 or older? If so, you may be able to participate in this study of a new treatment approach. Learn more: bit.ly/ea5221-achieve cc: @DrSteveMartin @efratdotan @CPresGeriOncMD

#ClinicalTrial EAQ221CD/CONCURxP monitors CDK4/6 inhibitor medication use with text message reminders & alerts for patients treated for #BreastCancer. For more information: bit.ly/EAQ221CD #bcsm cc: @GelarehSadigh, @ilana_graetz

#ClinicalTrial EA2222/PUMP, led by @michael_lidsky, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump cc: @MichaelDAngeli2, @skmaithel, @AndreaCercek

#ClinicalTrial EA2183, led by @NataliyaUboha of @UWHealth, is testing the addition of #radiotherapy to chemotherapy for patients w/ #esophageal and #GastricCancer. For more: bit.ly/ea2183 #StomachCancer #GICSM #esocsm

Principles in bsAb engineering, current understanding, & perspective on ongoing challenges by @mer_herreraMD @gedefo_sefh @pmcancercentre sciencedirect.com/science/articl… Thus far 7 bsAbs have been approved, including blinatumomab based on the results of the landmark @EAonc trial E1910.

Don't miss this Letter to the Editor by E1912 lead investigator Tait Shanafelt et al @BrJHaem-Pericardial events associated with ibrutinib-based therapies for #ChronicLymphocyticLeukemia in 2 landmark studies-E1912 & A041202 @ALLIANCE_org onlinelibrary.wiley.com/doi/10.1111/bj… #CLL #LKSM

Do you have #ProstateCancer that has returned after prostatectomy? If so, you may be able to participate in this study of potential new treatment approaches. Learn more about the EA8191/INDICATE study: bit.ly/indicate-trial #pcsm #ProstateCancerAware

The #ComboMATCH Study, led by researchers from @StanfordCancer, @MDAndersonNews, @PennCancer, & @NCItreatment, is testing new combinations of anti-#cancer drugs, based on the characteristics of patients’ tumors. Learn more: bit.ly/ComboMATCH #PrecisionMedicine

The EA5221/ACHIEVE clinical study is testing two different treatment approaches for older adults with advanced non-small cell #LungCancer. Learn more: bit.ly/ea5221-achieve #NSCLC #LCSM

Imagine a future where #breastcancer screening is tailored to your individual risk factors. The TMIST trial could help make this possible. Learn more: bit.ly/tmist #bcsm #TMIST4BC cc: @RadiologyACR @NCIprevention

The MM1OA-EA02 clinical study is testing a new treatment approach for patients with #AcuteMyeloidLeukemia who are age 60 or older. Learn more: bit.ly/mm1oa-ea02-stu… #AML #leukemia

.@michael_lidsky of @DukeSurgOnc and @DukeCancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: bit.ly/ea2222-pump cc : @CCAlliance, @FightCRC, @NCCRTnews

Could #greentea catechins help prevent the progression of #prostatecancer in men on active surveillance? #Clinicaltrial EA8184, led by Dr. Nagi Kumar of @MoffittNews, aims to find out. Learn more: bit.ly/ea8184trial #pcsm cc: @jpowsang

Are you a teen or young adult #lymphoma survivor that has finished treatment? If so, you may be eligible to participate in the @cancergenomics_ study that could make a positive impact on the #AYA #cancer community. Learn more: bit.ly/eaq211-study #AYACancer #AYACSM

Learn about the EA8191/INDICATE study, treating #ProstateCancer that has come back after surgery with apalutamide and targeted radiation based on PET imaging. More information: bit.ly/ea8191indicate #pcsm

.@skmaithel of @WinshipAtEmory is leading EA2197/OPT-IN, a #ClinicalTrial for patients with incidentally discovered stage 2-3 #GallbladderCancer. Find more information here: bit.ly/EA2197 #gicsm

Do you have #HER2positive #BreastCancer? If so, you may be eligible to participate in the phase 2 #ClinicalTrial EA1211/DIRECT, testing if FDG-PET/CT imaging can better predict a patient's response to treatment than the usual approach. Learn more: bit.ly/EA1211

Ask your doctor about this important trial for healthy women that could improve #breastcancer screening strategies in the future. Learn more: bit.ly/tmist #bcsm #TMIST4BC cc: @RadiologyACR @NCIprevention

#ClinicalTrial MM1OA-EA02, led by @jaltmanmd of @LurieCancer, aims to improve results for older adults with #AcuteMyeloidLeukemia (#AML). Learn more: bit.ly/ea3211-study #BloodCancer #leukemia

EA2174 lead Jennifer Eads @PennCancer covers the findings. The trial added nivolumab to neoadjuvant chemoradiation for pts w esophageal/GEJ cancer. Insight = Further analysis is needed on how radiation impacts the efficacy of immune checkpoint inhibitors. youtube.com/watch?v=lAIQQL…

Do you have #KidneyCancer (#RenalCellCarcinoma) that has spread to 2-5 other locations in your body? If so, you may be able to participate in this study of a potential new treatment. Learn more: bit.ly/ea8211-study #kcsm

The EAQ211/@cancergenomics_ clinical study is evaluating the impact of social and genetic factors on outcomes in adolescent & young adult (#AYA) #cancer survivors. Learn more: bit.ly/eaq211-study #AYACancer #AYACSM

There is still time to submit a research abstract for early-career investigators interested in presenting your research as part of the upcoming Fall 2024 Group Meeting. The submission deadline is tomorrow, Thursday, September 12 at 11:59 PM (Eastern Time). ecog-acrin.org/research/mento…

Do you have advanced #cancer that has become worse following treatment, or advanced cancer for which no standard treatment exists? If so, you may be able to join the #ComboMATCH #PrecisionMedicine study. Learn more: bit.ly/ComboMATCH

ComboMATCH/EAY191-E5 tests how well #sotorasib with or without #panitumumab can treat patients with advanced #SolidTumors. For more information: bit.ly/combomatch-e5 cc: @NCItreatment, @kspencer725, @DocDustyD #PrecisionMedicine

.@Dr_AmerZeidan of @SmilowCancer & @YaleCancer is leading clinical study EA9171, testing if adding a new drug to the usual treatment for chronic myelogenous #leukemia could help patients. Learn more: bit.ly/ea9171-study #CML #leusm

The EA8211/SOAR clinical study is testing a new treatment approach for patients with #KidneyCancer that has spread to 2-5 other places in the body. Learn more: bit.ly/ea8211-study #kcsm

#Clinicaltrial EA8184, led by Dr. Nagi Kumar of @MoffittNews will evaluate if #greentea catechins can help prevent the progression of #prostatecancer in men on active surveillance. Learn more here: bit.ly/ea8184-trial #pcsm cc: @jpowsang

The EAQ211/@cancergenomics_ clinical study is evaluating the impact of social and genetic factors on outcomes in adolescent & young adult (#AYA) #cancer survivors. Learn more: bit.ly/eaq211-study #AYACancer #AYACSM

The EA3211 clinical study is testing a potential new treatment for patients with #HeadAndNeckCancer that has spread to a limited number of places. Learn more: bit.ly/ea3211-study #hncsm

.@skmaithel of @WinshipAtEmory is leading EA2197/OPT-IN, a #ClinicalTrial for patients with incidentally discovered stage 2-3 #GallbladderCancer. Find more information here: bit.ly/EA2197 #gicsm

EA1211/DIRECT aims to help doctors make better (more personalized) decisions around treatment for #patients with #HER2positive #BreastCancer. Consider learning more about this phase 2 #clinicaltrial if you have HER2-positive breast cancer. For more info: bit.ly/EA1211

#ClinicalTrial EAQ221CD/CONCURxP monitors CDK4/6 inhibitor medication use with text message reminders & alerts for patients treated for #BreastCancer. For more information: bit.ly/EAQ221CD #bcsm cc: @GelarehSadigh, @ilana_graetz

Do you have newly diagnosed #Glioblastoma? If so, you may be able to participate in this study of a new treatment approach. Learn more about EAF223/GABLE here: bit.ly/gable-trial

#ClinicalTrial EA8211/SOAR, led by @Raquib_Hannan of @utswcancer, aims to improve the care and quality of life of certain patients with #KidneyCancer. Learn more: bit.ly/ea8211-study #kcsm

Kudos to @SaintAlsHealth for enrolling their first patient in #ClinicalTrial EA5182. This study explores AZD9291 (osimertinib) with or without bevacizumab as initial treatment for patients with EGFR-mutant #LungCancer. bit.ly/ea5182 cc: @HelenaYu923, @DrSteveMartin

Do you have squamous cell carcinoma of the head and neck that has spread to a limited number of places? If so, you may be eligible to participate in this study of a potential new treatment. Learn more: bit.ly/ea3211-study #HeadAndNeckCancer #HNSCC

Kudos to @UMRogelCancer for enrolling their first patient in phase III randomized #ClinicalTrial EA9181! This study is for adults with newly diagnosed BCR-ABL-positive acute lymphoblastic #leukemia. Learn more: bit.ly/ea9181trial #ALL #leusm

Have you had surgery for squamous cell carcinoma of the head and neck (#HNSCC) that has come back? If so, you may be able to participate in this study of a potential new treatment. Learn more: bit.ly/ea3191-study #HeadAndNeckCancer #HNCA

The EA5221/ACHIEVE clinical study is testing two different treatment approaches for older adults with advanced non-small cell #LungCancer. Learn more: bit.ly/ea5221-achieve #NSCLC #LCSM

#ClinicalTrial EAQ221CD/CONCURxP strives to improve medication adherence in #metastatic #BreastCancer patients. If you have a new prescription for a CDK4/6 inhibitor you may be eligible. Learn more here: bit.ly/EAQ221CD

The EAF223/GABLE clinical study is testing different imaging techniques that could help make better predictions about #BrainCancer progression. Learn more here: bit.ly/gable-trial
cc: @DukeRadiology, @glioblastf, @gbmfoundation

Don't miss this story of resilience. It tells how one patient’s role in #clinicaltrial E1910 for acute lymphocytic leukemia therapy brought a cancer-free diagnosis and FDA approval. Thank you, Becky Yu + @SelinaLugerMD @PennCancer, for sharing your story. #blinatumomab #blincyto x.com/PennCancer/sta…

#ClinicalTrial EA2183, led by @NataliyaUboha of @UWHealth, is testing the addition of #radiotherapy to chemotherapy for patients w/ #esophageal and #GastricCancer. For more: bit.ly/ea2183 #StomachCancer #GICSM #esocsm

The EA3211 clinical study is testing a potential new treatment for patients with #HeadAndNeckCancer that has spread to a limited number of places. Learn more: bit.ly/ea3211-study #hncsm